We are live on
!
Find out more
New York State Common Retirement Fund Portfolio holdings
AUM
$79.3B
1-Year Est. Return
43.63%
This Fund
S&P 500
This Quarter
Est. Return
-14.97%
1 Year Est. Return
+43.63%
3 Year Est. Return
+132.82%
5 Year Est. Return
+173.87%
10 Year Est. Return
+697.67%
AUM
$76.6B
AUM Growth
-$16.9B
(-18%)
Cap. Flow
-$974M
Cap. Flow
% of AUM
-1.27%
Top 10 Holdings %
Top 10 Hldgs %
22.59%
Holding
3,645
New
297
Increased
1,013
Reduced
2,105
Closed
75
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$263M |
| 2 |
ConocoPhillips
COP
|
+$84.8M |
| 3 |
Airbnb
ABNB
|
+$84.6M |
| 4 |
Chevron
CVX
|
+$59.4M |
| 5 |
Salesforce
CRM
|
+$56.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$142M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$112M |
| 3 |
AT&T
T
|
+$94.5M |
| 4 |
UnitedHealth
UNH
|
+$79M |
| 5 |
NXP Semiconductors
NXPI
|
+$77.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.7% |
| 2 | Healthcare | 15.99% |
| 3 | Financials | 13.43% |
| 4 | Consumer Discretionary | 10.38% |
| 5 | Industrials | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Kaltura
KLTR
$255M
| $1K | ﹤0.01% |
500
-2,750
| -85% | -$4.71K |
|
3302
Kopin
KOPN
$782M
| $1K | ﹤0.01% |
676
-52,500
| -99% | -$78.8K |
|
3303
KVH Industries
KVHI
$151M
| $1K | ﹤0.01% |
105
-3,636
| -97% | -$29.6K |
|
3304
Standard BioTools
LAB
$307M
| $1K | ﹤0.01% |
546
-51,819
| -99% | -$128K |
|
3305
Lineage Cell Therapeutics
LCTX
$288M
| $1K | ﹤0.01% |
907
-68,222
| -99% | -$90K |
|
3306
Limoneira
LMNR
$250M
| $1K | ﹤0.01% |
101
-8,236
| -99% | -$104K |
|
3307
Mayville Engineering Co
MEC
$585M
| $1K | ﹤0.01% |
75
-6,900
| -99% | -$58.5K |
|
|
LITS
3308
Lite Strategy Inc
LITS
$29.2M
| $1K | ﹤0.01% |
47
-2,673
| -98% | -$29.1K |
|
|
RJET
3309
Republic Airways Holdings
RJET
$960M
| $1K | ﹤0.01% |
19
-1,314
| -99% | -$61.8K |
|
3310
Mistras Group
MG
$499M
| $1K | ﹤0.01% |
163
-8,365
| -98% | -$49.5K |
|
|
KG
3311
Kestrel Group
KG
$70.4M
| $1K | ﹤0.01% |
21
-1,774
| -99% | -$79.4K |
|
3312
Matrix Service
MTRX
$329M
| $1K | ﹤0.01% |
175
-16,162
| -99% | -$101K |
|
3313
Nathan's Famous
NATH
$402M
| $1K | ﹤0.01% |
20
-2,307
| -99% | -$117K |
|
3314
National CineMedia
NCMI
$373M
| $1K | ﹤0.01% |
60
-2,568
| -98% | -$43.4K |
|
3315
NN Inc
NNBR
$308M
| $1K | ﹤0.01% |
365
-20,200
| -98% | -$56K |
|
|
IMDX
3316
Insight Molecular Diagnostics
IMDX
$154M
| $1K | ﹤0.01% |
29
-1,775
| -98% | -$40.4K |
|
3317
Oil-Dri
ODC
$1.29B
| $1K | ﹤0.01% |
64
-10,622
| -99% | -$139K |
|
3318
Olema Pharmaceuticals
OLMA
$1.05B
| $1K | ﹤0.01% |
207
-17,600
| -99% | -$55.8K |
|
3319
Omeros
OMER
$958M
| $1K | ﹤0.01% |
438
-40,998
| -99% | -$139K |
|
3320
Oric Pharmaceuticals
ORIC
$1.37B
| $1K | ﹤0.01% |
283
-19,300
| -99% | -$77K |
|
3321
Oramed Pharmaceuticals
ORMP
$175M
| $1K | ﹤0.01% |
260
-21,404
| -99% | -$114K |
|
3322
Passage Bio
PASG
$14.7M
| $1K | ﹤0.01% |
15
-1,270
| -99% | -$59.3K |
|
3323
PAVmed
PAVM
$34.4M
| $1K | ﹤0.01% |
1
-99
| -99% | -$47.8K |
|
3324
Puma Biotechnology
PBYI
$451M
| $1K | ﹤0.01% |
252
-28,147
| -99% | -$70K |
|
3325
Park-Ohio Holdings
PKOH
$713M
| $1K | ﹤0.01% |
55
-6,020
| -99% | -$84.6K |
|
Similar funds
CBU
New York State Common Retirement Fund's Q2 2022 Portfolio in Review
As of Q2 2022, New York State Common Retirement Fund held 3,645 positions worth $76.6B, down 18% from $93.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
New York State Common Retirement Fund's Q2 2022 filing shows 297 new, 1,013 increased, 2,105 reduced and 75 closed positions. Its largest new stake was Gerdau: 4,099,701 shares worth $14M. The largest sale was Apple, an estimated $142M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- New York State Common Retirement Fund's largest Q2 2022 buy was Gerdau: 4,099,701 shares worth $14M.
- New York State Common Retirement Fund added most to Linde in Q2 2022, an estimated $263M increase.
- New York State Common Retirement Fund's biggest Q2 2022 reduction was Apple, cutting an estimated $142M.
- New York State Common Retirement Fund fully exited Anaplan, Inc. in Q2 2022, selling an estimated $53.5M.
- New York State Common Retirement Fund's ten largest holdings make up 23% of its $76.6B portfolio in Q2 2022.
- New York State Common Retirement Fund opened 297 new positions and closed 75 in Q2 2022.
- New York State Common Retirement Fund's portfolio value fell 18% quarter-over-quarter to $76.6B.
Based on New York State Common Retirement Fund's 13F filing for Q2 2022, filed 4 Aug 2022.